Xencor (XNCR)
(Delayed Data from NSDQ)
$22.42 USD
+0.89 (4.13%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $22.43 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Brokerage Reports
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 1 - 20 ( 215 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for XNCR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
ESMO 2023 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
XmAb808 (B7-H3 x CD28) preclinical platform validation on two fronts
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Biotechnology- ASH Day 3 Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D